MedTrace Logo

Three-Year Trial on a New Testosterone Gel

NCT00204269 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2006-05-15

No results posted yet for this study

Summary

The objective of the study is to examine the efficacy and tolerability of a three-year-Testosterone replacement therapy in hypogonadal patients as well as the patient's compliance. The replacement therapy will be performed with a new Testosterone Gel examined in previous trials as Testosteron Gel Wolff.

Conditions

  • Hypogonadism

Interventions

DRUG

Testosterone Gel Wolff

Sponsors & Collaborators

  • Dr. August Wolff GmbH & Co. KG Arzneimittel

    collaborator INDUSTRY

  • University Hospital Muenster

    lead OTHER

Principal Investigators

  • Eberhard Nieschlag, Prof. Dr. · Institute of Reproductive Medicine of the University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-01-31
Completion
2006-09-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00204269 on ClinicalTrials.gov